Ali̇ Ayhan

Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial

Domenica Lorusso, Yang Xiang, Kosei Hasegawa et al. · The Lancet · 2024 · 296 citations

Advanced Cervical Cancer, Cervical Cancer, Cervical Health +9

Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study

James Glasbey, Adesoji Ademuyiwa, Adewale Adisa et al. · The Lancet Oncology · 2021 · 280 citations · Full text

Mature cystic teratomas of the ovary: case series from one institution over 34 years

Ali̇ Ayhan · European Journal of Obstetrics & Gynecology and Reproductive Biology · 2000 · 256 citations

Mature Cystic Teratomas, Gynecology, Ovarian Cancer +1

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort

Rongyu Zang, Philipp Harter, D. S. et al. · British Journal of Cancer · 2011 · 136 citations · Full text

A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection

Wen-Juan Tian, S. Dennis, Jalid Sehouli et al. · Annals of Surgical Oncology · 2011 · 126 citations

Gynecologic Surgery, Surgical Oncology, Risk Model +11